Swiss National Bank’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-48,800
| Closed | -$3.31M | – | 2584 |
|
|
2019
Q3 | $3.31M | Buy |
48,800
+800
| +2% | +$54.9K | ﹤0.01% | 1362 |
|
|
2019
Q2 | $2.79M | Buy |
48,000
+8,500
| +22% | +$504K | ﹤0.01% | 1495 |
|
|
2019
Q1 | $2.77M | Buy |
39,500
+1,500
| +4% | +$111K | ﹤0.01% | 1457 |
|
|
2018
Q4 | $2.45M | Buy |
38,000
+1,700
| +5% | +$119K | ﹤0.01% | 1436 |
|
|
2018
Q3 | $2.55M | Hold |
36,300
| – | – | ﹤0.01% | 1564 |
|
|
2018
Q2 | $1.83M | Hold |
36,300
| – | – | ﹤0.01% | 1763 |
|
|
2018
Q1 | $1.14M | Buy |
36,300
+2,400
| +7% | +$79.6K | ﹤0.01% | 2008 |
|
|
2017
Q4 | $1.16M | Hold |
33,900
| – | – | ﹤0.01% | 1998 |
|
|
2017
Q3 | $1.09M | Hold |
33,900
| – | – | ﹤0.01% | 2007 |
|
|
2017
Q2 | $1.1M | Buy |
33,900
+2,700
| +9% | +$85.5K | ﹤0.01% | 1992 |
|
|
2017
Q1 | $982K | Hold |
31,200
| – | – | ﹤0.01% | 2047 |
|
|
2016
Q4 | $917K | Hold |
31,200
| – | – | ﹤0.01% | 2090 |
|
|
2016
Q3 | $902K | Hold |
31,200
| – | – | ﹤0.01% | 2028 |
|
|
2016
Q2 | $808K | Buy |
31,200
+700
| +2% | +$18.6K | ﹤0.01% | 2087 |
|
|
2016
Q1 | $731K | Buy |
30,500
+5,400
| +22% | +$148K | ﹤0.01% | 2095 |
|
|
2015
Q4 | $884K | Hold |
25,100
| – | – | ﹤0.01% | 1908 |
|
|
2015
Q3 | $531K | Buy |
25,100
+3,200
| +15% | +$82.5K | ﹤0.01% | 2155 |
|
|
2015
Q2 | $609K | Buy |
21,900
+2,300
| +12% | +$64.9K | ﹤0.01% | 2114 |
|
|
2015
Q1 | $599K | Hold |
19,600
| – | – | ﹤0.01% | 2075 |
|
|
2014
Q4 | $627K | Hold |
19,600
| – | – | ﹤0.01% | 2037 |
|
|
2014
Q3 | $555K | Hold |
19,600
| – | – | ﹤0.01% | 2040 |
|
|
2014
Q2 | $537K | Hold |
19,600
| – | – | ﹤0.01% | 2128 |
|
|
2014
Q1 | $516K | Buy |
19,600
+4,100
| +26% | +$118K | ﹤0.01% | 2106 |
|
|
2013
Q4 | $454K | Hold |
15,500
| – | – | ﹤0.01% | 2046 |
|
|
2013
Q3 | $474K | Sell |
15,500
-900
| -5% | -$30.1K | ﹤0.01% | 1974 |
|
|
2013
Q2 | $520K | Buy |
+16,400
| New | +$539K | ﹤0.01% | 1886 |
|
Swiss National Bank's GHDX Position: Q4 2019 in Review
Swiss National Bank sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 48,800 shares — an estimated $3.31M sold.
Swiss National Bank first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $3.31M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Swiss National Bank reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Swiss National Bank sold 48,800 Genomic Health, Inc. shares in Q4 2019, an estimated $3.31M.
- Swiss National Bank first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- Swiss National Bank's Genomic Health, Inc. position peaked at $3.31M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.